IMRIS (IMRSQ) EBIT: $-25.57 Mil (TTM As of Dec. 2014)


What is IMRIS EBIT?

IMRIS IMRSQ EBIT is $-25.57 Mil as of Dec. 2014.

IMRIS's earnings before interest and taxes (EBIT) for the three months ended in Dec. 2014 was $-5.34 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Dec. 2014 was $-25.57 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. IMRIS's annualized ROC % for the quarter that ended in Dec. 2014 was -37.89%. IMRIS's annualized ROC (Joel Greenblatt) % for the quarter that ended in Dec. 2014 was -147.52%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield.

IMRIS  (OTCPK:IMRSQ) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

IMRIS's annualized ROC % for the quarter that ended in Dec. 2014 is calculated as:

ROC % (Q: Dec. 2014 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Sep. 2014 ) + Invested Capital (Q: Dec. 2014 ))/ count )
=-17.964 * ( 1 - 0% )/( (45.37 + 49.453)/ 2 )
=-17.964/47.4115
=-37.89 %

where

Invested Capital(Q: Sep. 2014 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=59.532 - 10.32 - ( 3.842 - max(0, 22.787 - 28.062+3.842))
=45.37

Invested Capital(Q: Dec. 2014 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=65.484 - 12.995 - ( 5.002 - max(0, 31.723 - 34.759+5.002))
=49.453

Note: The Operating Income data used here is four times the quarterly (Dec. 2014) data.

2. Joel Greenblatt's definition of Return on Capital:

IMRIS's annualized ROC (Joel Greenblatt) % for the quarter that ended in Dec. 2014 is calculated as:

ROC (Joel Greenblatt) %(Q: Dec. 2014 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Sep. 2014  Q: Dec. 2014
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=-21.34/( ( (14.621 + max(-3.553, 0)) + (14.311 + max(-7.882, 0)) )/ 2 )
=-21.34/( ( 14.621 + 14.311 )/ 2 )
=-21.34/14.466
=-147.52 %

where Working Capital is:

Working Capital(Q: Sep. 2014 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(3.705 + 9.495 + 3.578) - (10.32 + 10.011 + 0)
=-3.553

Working Capital(Q: Dec. 2014 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(8.539 + 9.13 + 3.716) - (12.995 + 16.272 + 0)
=-7.882

When net working capital is negative, 0 is used.

Note: The EBIT data used here is four times the quarterly (Dec. 2014) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

IMRIS's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %=EBIT (TTM)/Enterprise Value (Q: Dec. 2014 )
=-25.568/0.000
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

IMRIS EBIT Related Terms

IMRIS EBIT Historical Data

* Premium members only.

The historical data trend for IMRIS's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

IMRIS EBIT Chart

IMRIS Annual Data
Trend Dec06 Dec07 Dec08 Dec09 Dec10 Dec11 Dec12 Dec13 Dec14
EBIT
Get a 7-Day Free Trial Premium Member Only -0.98 -20.57 -27.63 -40.63 -25.57

IMRIS Quarterly Data
Mar10 Jun10 Sep10 Dec10 Mar11 Jun11 Sep11 Dec11 Mar12 Jun12 Sep12 Dec12 Mar13 Jun13 Sep13 Dec13 Mar14 Jun14 Sep14 Dec14
EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -20.51 -6.83 -6.09 -7.31 -5.34

IMRSQ vs IVOB, IGNG, IRIX: EBIT Comparison

For the Medical Devices subindustry, IMRIS's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

IMRIS EV-to-EBIT vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, IMRIS's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where IMRIS's EV-to-EBIT falls into.


IMRIS EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Dec. 2014 adds up the quarterly data reported by the company within the most recent 12 months, which was $-25.57 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EBIT →
What does a EBIT of $-25.57 Mil mean?
IMRIS (IMRSQ) has a EBIT of $-25.57 Mil as of Dec. 2014. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on IMRIS.
Is IMRIS's EBIT too high?
IMRIS's current EBIT is $-25.57 Mil.
How does IMRIS's EBIT compare to IVOB and IGNG?
IMRIS's EBIT of $-25.57 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT for a Medical Devices & Instruments company?
A good EBIT depends on the Medical Devices & Instruments industry context. However, EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT mean?
A high EBIT can signal that a stock is expensive relative to its fundamentals. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on IMRIS. IMRIS's current EBIT is $-25.57 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is IMRIS stock overvalued right now?
IMRIS (IMRSQ) has a current EBIT of $-25.57 Mil. The current EBIT is $-25.57 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT calculated?
EBIT is calculated from a company's financial statements. For IMRIS (IMRSQ), the current EBIT is $-25.57 Mil as of Dec. 2014. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

IMRIS Business Description

Address 1230 Chaska Creek Way, Suite 100, Chaska, MN, USA, 55318
IMRIS Inc provides integrated intraoperative imaging environments that deliver real-time MRI and imaging data during surgical and interventional procedures. The Operating Suite of the company enables imaging directly within the OR, enhancing clinical decision-making. The company also designs and manufactures proprietary head fixation devices, imaging coils, and OR tables tailored for this specialized setting.